Advanced search×

Osteopontin: role in cell signaling and cancer progression

Trends Cell Biol 16(2):9 (2006) PMID 16406521

Cell migration and degradation of the extracellular matrix (ECM) are crucial steps in tumor progression. Several matrix-degrading proteases, including matrix metalloproteases, are highly regulated by growth factors, cytokines and ECM proteins. Osteopontin (OPN), a chemokine-like, calcified ECM-associated protein, plays a crucial role in determining the metastatic potential of various cancers. Since its first identification in bone, the multifaceted roles of OPN have been an area of intense investigation. Extensive research has elucidated the pivotal role of OPN in regulating the cell signaling that controls tumor progression and metastasis. This review focuses on recent advances in understanding the functional role of the OPN-induced signaling pathway in the regulation of cell migration and tumor progression and the implications for identifying novel targets for cancer therapy.

DOI: 10.1016/j.tcb.2005.12.005
Version: za2963e q8za0 q8zb6 q8zc0 q8zd5 q8ze5 q8zf3 q8zg6

Similar articles you may find interesting…

  1. Adriamycin nephropathy: a model of focal segmental glomerulosclerosis.

    Nephrology (Carlton) 16(1):30-8 (2011) PMID 21175974

    Adriamycin nephropathy (AN) is a rodent model of chronic kidney disease that has been studied extensively and has enabled a greater understanding of the processes underlying the progression of chronic proteinuric renal disease. AN is characterized by podocyte injury followed by glomerulosclerosis, t...
  2. Role of the podocyte in proteinuria.

    Pediatr Nephrol 26(10):1775-80 (2011) PMID 21184239 PMCID PMC3163769

    We proposed a novel model in which an electrical potential difference is generated across the glomerular filtration barrier by filtration. The model offers novel potential solutions to some of the riddles regarding the glomerular filter....
  3. Pathogenic role of TGF-β in the progression of podocyte diseases.

    Histol Histopathol 26(1):107-16 (2011) PMID 21117032

    In patients with progressive podocyte diseases, such as focal segmental glomerulosclerosis and membranous nephropathy, there is enhanced expression of transforming growth factor (TGF-β) in podocytes. Biomechanical strain in these diseases may cause overexpression of TGF-β and angiotensin II (Ang I...